Alon USA Partners, LP Reports Third Quarter 2017 Results and Declares Quarterly Cash Distribution
Nov 08, 2017 21:53 pm UTC| Business
BRENTWOOD, Tenn., Nov. 08, 2017 -- Alon USA Partners, LP (NYSE:ALDW) (“Alon Partners”) today announced results for the third quarter of 2017. Net income for the third quarter of 2017 was $29.2 million, or $0.47 per...
Delek US Holdings to Acquire Remaining 18.4 Percent of Outstanding Units of Alon USA Partners
Nov 08, 2017 21:52 pm UTC| Business
All-stock transaction at a fixed exchange ratio of 0.49 Delek US shares for each Alon USA Partners common unitTransaction simplifies the corporate structure of Delek US BRENTWOOD, Tenn., Nov. 08, 2017 -- Delek US...
Mortgage Lending Services Welcomes Eight Mortgage Consultants
Nov 08, 2017 21:50 pm UTC| Business
PLYMOUTH, Minn., Nov. 08, 2017 -- Mortgage Lending Services, LLC, a TruStone Financial company, recently welcomed eight mortgage consultants to its growing business. Each of the mortgage consultants has a strong...
James River Group Holdings Announces Secondary Offering
Nov 08, 2017 21:46 pm UTC| Business
PEMBROKE, Bermuda, Nov. 08, 2017 -- James River Group Holdings, Ltd. (NASDAQ:JRVR) (“James River” or the “Company”) announced today that certain of the Company’s shareholders intend to offer in an underwritten public...
Precision Optics Corporation Schedules First Quarter Conference Call
Nov 08, 2017 21:45 pm UTC| Business
GARDNER, Mass., Nov. 08, 2017 -- Precision Optics Corporation, Inc. (OTCQB:PEYE) (the "Company") announced that it intends to release its financial results for the fiscal year 2018 first quarter ended September 30, 2017...
Enstar Group Limited Reports Third Quarter Results
Nov 08, 2017 21:43 pm UTC| Business
HAMILTON, Bermuda, Nov. 08, 2017 -- Enstar Group Limited (Nasdaq:ESGR) filed its quarterly report on Form 10-Q with the SEC today, reporting its earnings and financial position for the three and nine months ended...
Nov 08, 2017 21:41 pm UTC| Business
CORAL GABLES, Fla., Nov. 08, 2017 -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating,...